# OnCo record toremifene (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/toremifene/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "toremifene" ;
  schema:name "Toremifene"@en ;
  schema:description "Toremifene (Fareston) is a tamoxifen-like tablet for postmenopausal women with hormone-sensitive breast cancer that has spread."@en ;
  schema:url <https://onco.cc/drugs/toremifene/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Toremifene> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=toremifene>, <https://www.cancer.gov/about-cancer/treatment/drugs/toremifene>, <https://www.ema.europa.eu/en/medicines/human/EPAR/fareston> ;
  onco:status "approved" ;
  onco:tag "nci-list" ;
  onco:modality "Selective oestrogen receptor modulator (triphenylethylene)" ;
  schema:alternateName "Fareston" ;
  onco:approval "US 1997: Metastatic breast cancer in postmenopausal women with ER-positive or unknown tumours", "EU 1996: First-line hormonal treatment of hormone-dependent metastatic breast cancer in postmenopausal women" ;
  onco:related <https://onco.cc/drugs/tamoxifen/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/> ;
  onco:companies <https://onco.cc/companies/kyowa-kirin/>, <https://onco.cc/companies/gtx/> ;
  onco:trials <https://onco.cc/trials/nct00129142/>, <https://onco.cc/trials/nct03351062/>, <https://onco.cc/trials/nct02132390/> .